Genetic Testing and Molecular Biomarkers · 2013 · 55 citations · 13 references
MedicineMolecular MedicineOncologyCancer PharmacologyMolecular OncologyNeoplasiaCancer BiomarkersEsophageal CancerMalignant NeoplasmsMicrorna BiologyNoncoding Rna In CancerSquamous Cell CarcinomaCorrelationMicrorna Expression AnalysisMicrorna Expression ProfilingMicrorna In CancerMicrorna Prognostic MarkersMicrorna-mediated ResistanceQuantitative Pcr DetectionReal-time Polymerase Chain Reaction (Pcr)
BACKGROUND AND AIMS: Here, we have investigated the role of miR-483 and miR-214 in the prognosis and multidrug resistance (MDR) of esophageal squamous cell carcinoma. METHODS: The expression of miR-483 and miR-214 was detected in 104 cases of esophageal cancer tissues and matched adjacent benign esophageal tissues by quantitative real-time PCR. The relation of microRNA expression with survival was statistically analyzed. The roles of miR-483 and miR-214 in MDR of esophageal squamous cell cancer cells were further evaluated. RESULTS: The expression of miR-483 and miR-214 was found significantly upregulated in esophageal squamous cell cancer tissues. The expression levels of miR-483 and miR-214 showed an inverse correlation with overall survival. High expression of miR-483 and miR-214 might predict less chemotherapy effect. Downregulation of miR-483 and miR-214 could confer sensitivity of both P-glycoprotein-related and P-glycoprotein-nonrelated drugs to esophageal cancer cells, and it might induce increased accumulation of adriamycin (ADR) and decreased amount of ADR released. CONCLUSIONS: miR-483 and miR-214 might play important roles in the pathogenesis of esophageal cancer and should be considered as potential targets for intervention in this malignancy.
13
Oncogenic Role of <i>miR-483-3p</i> at the <i>IGF2/483</i> Locus
Angelo Veronese, Laura Lupini, Jessica Consiglio et al. · Cancer Research · 2010 · 213 citations · Full text
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Xingju Zhang, Hua Ye, Chengwu Zeng et al. · Journal of Hematology & Oncology · 2010 · 193 citations · Full text
Medicine, Cancer Biology, Oncology +13
MicroRNA profiling of adrenocortical tumors reveals miR‐483 as a marker of malignancy
Erin E. Patterson, Alisha K. Holloway, Julie Weng et al. · Cancer · 2010 · 166 citations · Full text